Northwest Biothrputcs Inc (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,162 | -61,550 | -34,721 | -19,343 | -83,778 |
| Depreciation Amortization | 3,951 | 2,609 | 1,744 | 768 | 4,220 |
| Accounts payable and accrued liabilities | 7,752 | 8,855 | 7,534 | 4,375 | 8,937 |
| Other Working Capital | 12,963 | 13,899 | 11,251 | 6,380 | 10,003 |
| Other Operating Activity | -9,267 | 6,188 | -1,914 | -1,598 | 3,601 |
| Operating Cash Flow | $-44,763 | $-29,999 | $-16,106 | $-9,418 | $-57,017 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,504 | -599 | -397 | -93 | -1,014 |
| Other Investing Activity | -311 | -311 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,815 | $-910 | $-397 | $-93 | $-1,014 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 31,255 | 19,682 | 12,507 | 7,200 | 34,015 |
| Debt Repayment | -1,011 | -1,011 | -536 | -536 | -1,110 |
| Common Stock Issued | 19,342 | 17,327 | 12,465 | 5,140 | 15,752 |
| Other Financing Activity | -259 | -259 | -255 | -71 | 8,128 |
| Financing Cash Flow | $49,327 | $35,739 | $24,181 | $11,733 | $56,785 |
| Exchange Rate Effect | -1,884 | -2,445 | -5,537 | -1,618 | 1,295 |
| Beginning Cash Position | 2,175 | 2,175 | 2,175 | 2,175 | 2,126 |
| End Cash Position | 3,040 | 4,560 | 4,316 | 2,779 | 2,175 |
| Net Cash Flow | $865 | $2,385 | $2,141 | $604 | $49 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,763 | -29,999 | -16,106 | -9,418 | -57,017 |
| Capital Expenditure | -1,504 | -599 | -397 | -93 | -1,014 |
| Free Cash Flow | -46,267 | -30,598 | -16,503 | -9,511 | -58,031 |